VEGF receptor 2 inhibitor nintedanib completely reverts VEGF-A165-induced disturbances of barriers formed by retinal endothelial cells or long-term cultivated ARPE-19 cells-Reference-Cited by-同舟云学术

VEGF receptor 2 inhibitor nintedanib completely reverts VEGF-A165-induced disturbances of barriers formed by retinal endothelial cells or long-term cultivated ARPE-19 cells

Published:2020-05 Issue: Volume:194 Page:108004
ISSN:0014-4835
Container-title:Experimental Eye Research
language:en
Short-container-title:Experimental Eye Research

Author:

Deissler Heidrun L.,Stutzer Jan-Niklas,Lang Gerhard K.,Grisanti Salvatore,Lang Gabriele E.,Ranjbar Mahdy

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Reference58 articles.

1. VEGF modulation of retinal pigment epithelium resistance;Ablonczy;Exp. Eye Res.,2007

2. Pigment epithelium-derived factor maintains retinal pigment epithelium function by inhibiting vascular endothelial growth factor-R2 signaling through γ-secretase;Ablonczy;J. Biol. Chem.,2009

3. Human retinal pigment epithelium cells as functional models for the RPE in vivo;Ablonczy;Invest. Ophthalmol. Vis. Sci.,2011

4. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders;Aiello;N. Engl. J. Med.,1994

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protective effect of Cyanidin-3-O-glucoside from blueberry anthocyanin extracts against hyperglycemia-induced outer BRB damage by suppressing REDD1-mediated VEGFA upregulation;Food Bioscience;2024-10

2. VEGF-A165a and angiopoietin-2 differently affect the barrier formed by retinal endothelial cells;Experimental Eye Research;2024-10

3. Pirfenidone and nintedanib attenuates pulmonary artery endothelial and smooth muscle cells transformations induced by IL-11;European Journal of Pharmacology;2024-06

4. Synergic effects of EP2 and FP receptors co-activation on Blood-Retinal Barrier and Microglia;Experimental Eye Research;2023-12

5. Effect of a novel tyrosine kinase inhibitor nintedanib on bFGF and VEGF concentrations in a rabbit retinal vein occlusion model;International Journal of Ophthalmology;2023-09-18